Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radek Skoda

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Hematology. American Society of Hematology. Education Program|November 21, 2007
The genetic basis of myeloproliferative disordersRadek Skoda
European Journal of Haematology. Supplementum|August 31, 2007
Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disordersRadek Skoda
European Journal of Haematology. Supplementum|August 31, 2007
Advances in the understanding and management of myeloproliferative disordersRadek Skoda
Current Protocols in Mouse Biology|June 13, 2015
Hematology Testing in MicePontus Lundberg, Radek Skoda
Haematologica|July 6, 2005
Gain of function, loss of control - a molecular basis for chronic myeloproliferative disordersMario Cazzola, Radek Skoda
Seminars in Hematology|October 8, 2005
Chronic myeloproliferative disorders--introductionRadek Skoda, Josef T Prchal
Seminars in Hematology|October 8, 2005
Lessons from familial myeloproliferative disordersRadek Skoda, Josef T Prchal
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Sodium scandium diphosphate, NaScP(2)O(7), isotypic with α-NaTi(III)P(2)O(7)Jan Cempírek, Radek Skoda, Zdirad Zák
Nature Reviews. Clinical Oncology|October 7, 2009
Myeloproliferative neoplasms: contemporary diagnosis using histology and geneticsAyalew Tefferi, Radek Skoda, James W Vardiman
European Journal of Haematology. Supplementum|August 31, 2007
Myeloproliferative disorders: a time of new definitions. Outflow from New Horizons in Haematology Meeting, 9-10 March 2007Radek Skoda, Tiziano Barbui, John T Reilly
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Hematology. American Society of Hematology. Education Program|November 21, 2007
The genetic basis of myeloproliferative disordersRadek Skoda
European Journal of Haematology. Supplementum|August 31, 2007
Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disordersRadek Skoda
European Journal of Haematology. Supplementum|August 31, 2007
Advances in the understanding and management of myeloproliferative disordersRadek Skoda
Current Protocols in Mouse Biology|June 13, 2015
Hematology Testing in MicePontus Lundberg, Radek Skoda
Haematologica|July 6, 2005
Gain of function, loss of control - a molecular basis for chronic myeloproliferative disordersMario Cazzola, Radek Skoda
Seminars in Hematology|October 8, 2005
Chronic myeloproliferative disorders--introductionRadek Skoda, Josef T Prchal
Seminars in Hematology|October 8, 2005
Lessons from familial myeloproliferative disordersRadek Skoda, Josef T Prchal
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Sodium scandium diphosphate, NaScP(2)O(7), isotypic with α-NaTi(III)P(2)O(7)Jan Cempírek, Radek Skoda, Zdirad Zák
Nature Reviews. Clinical Oncology|October 7, 2009
Myeloproliferative neoplasms: contemporary diagnosis using histology and geneticsAyalew Tefferi, Radek Skoda, James W Vardiman
European Journal of Haematology. Supplementum|August 31, 2007
Myeloproliferative disorders: a time of new definitions. Outflow from New Horizons in Haematology Meeting, 9-10 March 2007Radek Skoda, Tiziano Barbui, John T Reilly
Pageof 3